news

Results announcement for the second quarter 2012

Posted: 25 July 2012 | | No comments yet

GSK delivers Q2 core EPS of 26.4p and dividend of 17p…

GlaxoSmithKline logo
  • Core EPS of 26.4p and dividend of 17p
  • Pharma and Vaccines sales in EMAP +9%, Japan +6%
  • Consumer Healthcare sales +7% (excluding divested brands & alli)
  • Pharma & Vaccines sales in Europe (-8%) & US (-6%) reflecting challenging macro-economy & continued transition of product portfolio
  • Full year sales now expected to be in line with 2011

Full announcement with CEO and CFO videos available in the Investors section of this website: http://www.gsk.com/investors/quarterly_results.htm.

 

Related organisations